U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: over 10,000 records

Showing results for "4.a-2 screening".

  1. Archived: Final Research Plan: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening-september-2016
    September 25, 2014 - Print archived Final Research Plan Latent Tuberculosis Infection: Screening … Screening may result in harms (key question 4). … Are there harms associated with screening for LTBI? … Do these harms differ by screening method or strategy? … Screening using TST or IGRA; studies using a single screening test or multiple tests in series

  2. Screening for Abdominal Aortic Aneurysm - Recommendation Statement (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/p8bwnFstpfy9KoDSJhT7m5
    February 01, 2005 - There is negligible health benefit in re-screening those who have normal aortic diameter on initial screening … Primary Care Screening for Abdominal Aortic Aneurysm. … The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening … Abdominal aortic aneurysm: screening and treatment. [Dutch]. … Results from a randomised population screening trial.

  3. Vision Screening in Children Aged 6Months to 5 Years: Evidence Report and Systematic Review (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Jwn6dWRHvK3C9oJCV6hLKc
    September 05, 2017 - No RCTs compared screening with no screening, and no studies evaluated school performance, function … do not establish whether vision screening in preschool children is better than no screening. … ) com­ pared orthoptist screening at age 3 years in 1 health district with no preschool screening in … No eligible RCTs directly compared screening with no screening. … whether vision screening in preschool children is better than no screening.

  4. Cc7S5Lxbfmohh5Zmmxjwkm (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/CC7S5LxbFmoHh5ZmMxJWkM
    February 01, 2016 - No studies provided results by age, risk factor, screening interval, or screening modality. … women but persists for others, and some women with false-positive results do not attend subsequent screenings … Although many women have pain during mammography, the propor- tion of those who do not attend subsequent screenings … and screening interval? … How do the harms† of routine breast cancer screening vary by screening modality§?

  5. Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_16-p001-1-ef.pdf
    April 01, 2016 - Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … results by a primary care clinician on the same day as the screening visit. … the critically important follow-up/referral component of screening … Developmental screening in children. 2011.

  6. Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_16-p001-1-ef.pdf
    April 01, 2016 - Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … results by a primary care clinician on the same day as the screening visit. … the critically important follow-up/referral component of screening … Developmental screening in children. 2011.

  7. Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_16-p001-1-ef.pdf
    April 01, 2016 - Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … results by a primary care clinician on the same day as the screening visit. … the critically important follow-up/referral component of screening … Developmental screening in children. 2011.

  8. Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_16-p001-1-ef.pdf
    April 01, 2016 - Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … results by a primary care clinician on the same day as the screening visit. … the critically important follow-up/referral component of screening … Developmental screening in children. 2011.

  9. Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_16-p001-1-ef.pdf
    April 01, 2016 - Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … results by a primary care clinician on the same day as the screening visit. … the critically important follow-up/referral component of screening … Developmental screening in children. 2011.

  10. Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_16-p001-1-ef.pdf
    April 01, 2016 - Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … results by a primary care clinician on the same day as the screening visit. … the critically important follow-up/referral component of screening … Developmental screening in children. 2011.

  11. Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_16-p001-1-ef.pdf
    April 01, 2016 - Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … Measure: Developmental Screening Follow-up: Follow-up with Patient Family After Developmental Screening … results by a primary care clinician on the same day as the screening visit. … the critically important follow-up/referral component of screening … Developmental screening in children. 2011.

  12. Abnormal Glucose Screening Part 1 Datarequirements (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/1061/Abnormal_Glucose_Screening_Part%201_DataRequirements.xlsx
    September 17, 2019 - Data Requirements Data Requirements: Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus … : Part 1, Screening This spreadsheet was created to assist with integration efforts (i.e., integrating

  13. Chipra202-Materials Via (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA202-Materials_VIA.pdf
    July 22, 2016 - between 6 and 36 months) Age at time of medical chart abstracti on Name of developmental screening … tool used Name of develop mental screening tool used, specify Evidence of a positive developme … ntal screening result* (yes - 1/ no - 2) If no evidence of determination of positive or negative … result* (yes - 1/ no - 2) same as column O Date of the positive developmental screening result … Follow-up After Screening by Race (All sites) and by center Reviewer 1 Reviewer 2 All Centers White

  14. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V77.0 Special screening for thyroid disorders 28. … V79.2 Special screening for mental retardation 29. … V82.5 Special screening for lead poisoning Source: “Developmental Screening Billing and Payment … Z13.29 Special screening for thyroid disorders 28. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  15. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V77.0 Special screening for thyroid disorders 28. … V79.2 Special screening for mental retardation 29. … V82.5 Special screening for lead poisoning Source: “Developmental Screening Billing and Payment … Z13.29 Special screening for thyroid disorders 28. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  16. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V77.0 Special screening for thyroid disorders 28. … V79.2 Special screening for mental retardation 29. … V82.5 Special screening for lead poisoning Source: “Developmental Screening Billing and Payment … Z13.29 Special screening for thyroid disorders 28. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  17. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V77.0 Special screening for thyroid disorders 28. … V79.2 Special screening for mental retardation 29. … V82.5 Special screening for lead poisoning Source: “Developmental Screening Billing and Payment … Z13.29 Special screening for thyroid disorders 28. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  18. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V77.0 Special screening for thyroid disorders 28. … V79.2 Special screening for mental retardation 29. … V82.5 Special screening for lead poisoning Source: “Developmental Screening Billing and Payment … Z13.29 Special screening for thyroid disorders 28. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  19. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V77.0 Special screening for thyroid disorders 28. … V79.2 Special screening for mental retardation 29. … V82.5 Special screening for lead poisoning Source: “Developmental Screening Billing and Payment … Z13.29 Special screening for thyroid disorders 28. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  20. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V77.0 Special screening for thyroid disorders 28. … V79.2 Special screening for mental retardation 29. … V82.5 Special screening for lead poisoning Source: “Developmental Screening Billing and Payment … Z13.29 Special screening for thyroid disorders 28. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (2921)

effectivehealthcare-admin.ahrq.gov (1694)

www.uspreventiveservicestaskforce.org (1652)

ce.effectivehealthcare.ahrq.gov (1510)

effectivehealthcare.ahrq.gov (1483)

psnet.ahrq.gov (1280)

digital.ahrq.gov (943)

www.qualitymeasures.ahrq.gov (777)

srdr.ahrq.gov (613)

www.talkingquality.ahrq.gov (567)

www.monahrq.ahrq.gov (546)

www.innovations.ahrq.gov (544)

www.healthcare411.ahrq.gov (542)

cmext.ahrq.gov (524)

www.cahps.ahrq.gov (494)

www.cpsi.ahrq.gov (359)

hcup-us.ahrq.gov (354)

cahps.ahrq.gov (259)

pbrn.ahrq.gov (259)

healthcare411.ahrq.gov (257)

monahrq.ahrq.gov (257)

pcmh.ahrq.gov (252)

talkingquality.ahrq.gov (217)

ahrqpubs.ahrq.gov (202)

patientregistry.ahrq.gov (201)

preventiveservices.ahrq.gov (193)

meps.ahrq.gov (177)

teamstepps.ahrq.gov (145)

cds.ahrq.gov (107)

ecareplan.ahrq.gov (63)

nhqrnet.ahrq.gov (45)

cdsic.ahrq.gov (39)

qualityindicators.ahrq.gov (30)

srdrplus.ahrq.gov (23)

staging-meps.ahrq.gov (22)

covid-acts.ahrq.gov (7)

pso.ahrq.gov (5)

datatools.ahrq.gov (3)

info.ahrq.gov (2)

cahpsdatabase.ahrq.gov (1)